InvestorsHub Logo
icon url

tscott4

12/25/20 7:47 AM

#23731 RE: Itchy palm #23730

Do you understand most trials get expanded at 75% mark. For example HGEN was given green light at 50%. But told to expand at 75%. I suggest you do your research.

Once again. They will not meet end point. Mortality at 190 people in total. That’s what 95 people getting leronimab. You think they know at 95 people the drug works. Noooooo. Science shows this does nothing for severe critical. You will find out soon.

But I’m watching for that HGEN news next week. Excited.